tradingkey.logo
tradingkey.logo
Search

Zura Bio Ltd

ZURA
Add to Watchlist
5.640USD
+0.210+3.87%
Close 07-31 16:00ETQuotes delayed by 15 min
415.56MMarket Cap
LossP/E TTM

ZURA Income Statement

You can find the annual or quarterly income statement of Zura Bio Ltd here for insights into the performance and operational efficiency of Zura Bio Ltd.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Operating expenses
32.43%25.50M
48.81%23.41M
1.04%19.52M
53.60%18.06M
129.79%19.25M
45.30%15.73M
89.64%19.32M
-65.32%11.76M
8.55%8.38M
1572.35%10.83M
1774.00%10.19M
3063.36%33.91M
1772.06%7.72M
25.83%647.41K
68.89%543.60K
5499.52%1.07M
1148.00%412.33K
--514.50K
--321.86K
--19.14K
--33.04K
R&D expenses
40.79%14.75M
72.68%15.96M
98.18%11.95M
57.14%8.70M
191.51%10.47M
33.53%9.24M
52.06%6.03M
-80.38%5.54M
-26.43%3.59M
--6.92M
--3.96M
--28.23M
--4.88M
----
----
----
----
----
----
----
----
Depreciation, depletion, and amortization
77.78%16.00K
200.00%15.00K
366.67%14.00K
1000.00%11.00K
--9.00K
--5.00K
--3.00K
--1.00K
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
----
--0.00
----
----
Operating profit
-32.43%-25.50M
-48.81%-23.41M
-1.04%-19.52M
-53.60%-18.06M
-129.79%-19.25M
-45.30%-15.73M
-89.64%-19.32M
65.32%-11.76M
-8.55%-8.38M
-1572.35%-10.83M
-1774.00%-10.19M
-3063.36%-33.91M
-1772.06%-7.72M
-25.83%-647.41K
-68.89%-543.60K
-5499.52%-1.07M
-1148.00%-412.33K
---514.50K
---321.86K
---19.14K
---33.04K
Net non-operating interest income (expenses)
Non-operating interest income
-27.41%1.32M
-39.98%1.28M
-37.99%1.53M
-21.81%1.72M
49.55%1.82M
55.18%2.13M
201.96%2.46M
--2.20M
--1.22M
472313.79%1.37M
363739.29%815.00K
----
----
1218.18%290.00
672.41%224.00
--42.00
--14.00
--22.00
--29.00
----
----
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
----
----
----
----
----
----
Gains from sale of securities
----
----
----
----
----
----
----
----
----
----
43.76%987.00K
----
----
9716.58%1.19M
9822.59%686.54K
--181.21K
--16.30K
--12.13K
--6.92K
----
----
Special income (expenses)
----
--5.00M
----
----
----
-100.00%0.00
-3348.74%-3.87M
-44.36%-768.00K
70.68%-606.00K
649.41%960.00K
-62.26%119.00K
-116.83%-532.00K
-480.05%-2.07M
-92.07%128.10K
-96.34%315.30K
--3.16M
--543.87K
--1.62M
--8.62M
----
----
Other non-operating income (expenses)
-760.00%-43.00K
-110.53%-40.00K
-313.64%-47.00K
17500.00%352.00K
-121.74%-5.00K
-179.17%-19.00K
650.00%22.00K
-99.51%2.00K
355.56%23.00K
--24.00K
---4.00K
--412.00K
---9.00K
--0.00
100.00%0.00
----
--0.00
--0.00
---2.52M
----
----
Income before tax
-38.88%-24.22M
-26.06%-17.18M
12.86%-18.04M
-54.84%-15.99M
-125.15%-17.44M
-60.80%-13.63M
-150.33%-20.70M
69.64%-10.33M
20.91%-7.75M
-1360.45%-8.47M
-1903.83%-8.27M
-1598.52%-34.02M
-6724.69%-9.79M
-39.64%672.22K
-92.08%458.47K
11962.39%2.27M
547.52%147.86K
--1.11M
--5.79M
---19.14K
---33.04K
Income tax
--0.00
----
--0.00
--0.00
--0.00
----
----
----
----
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
Income after tax
-38.88%-24.22M
-26.06%-17.18M
12.86%-18.04M
-54.84%-15.99M
-125.15%-17.44M
-60.80%-13.63M
-150.33%-20.70M
69.64%-10.33M
20.91%-7.75M
-1360.45%-8.47M
-1903.83%-8.27M
-1598.52%-34.02M
-6724.69%-9.79M
-39.64%672.22K
-92.08%458.47K
11962.39%2.27M
547.52%147.86K
--1.11M
--5.79M
---19.14K
---33.04K
Net income from continuous operations
-38.88%-24.22M
-26.06%-17.18M
12.86%-18.04M
-54.84%-15.99M
-125.15%-17.44M
-60.80%-13.63M
-150.33%-20.70M
69.64%-10.33M
20.91%-7.75M
-1360.45%-8.47M
-1903.83%-8.27M
-1598.52%-34.02M
-6724.69%-9.79M
-39.64%672.22K
-92.08%458.47K
11962.39%2.27M
547.52%147.86K
--1.11M
--5.79M
---19.14K
---33.04K
Net Income attributable to non-controlling interests
----
--0.00
---831.00K
--0.00
--0.00
100.00%0.00
--0.00
--0.00
100.00%0.00
---406.00K
--0.00
--0.00
---203.00K
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
-38.88%-24.22M
-407.08%-45.88M
12.66%-20.04M
-26.27%-15.99M
-2289.32%-17.44M
-44.12%-9.05M
-177.41%-22.94M
71.79%-12.67M
92.55%-730.00K
-1033.92%-6.28M
-1903.83%-8.27M
-2077.47%-44.90M
-6724.69%-9.79M
-39.64%672.22K
-92.08%458.47K
11962.39%2.27M
547.52%147.86K
--1.11M
--5.79M
---19.14K
---33.04K
Preferred share dividend
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--10.88M
----
----
----
----
----
----
----
----
----
Net income attributable to common shareholders
-38.88%-24.22M
-407.08%-45.88M
12.66%-20.04M
-26.27%-15.99M
-2289.32%-17.44M
-44.12%-9.05M
-177.41%-22.94M
71.79%-12.67M
92.55%-730.00K
-1033.92%-6.28M
-1903.83%-8.27M
-2077.47%-44.90M
-6724.69%-9.79M
-39.64%672.22K
-92.08%458.47K
11962.39%2.27M
547.52%147.86K
--1.11M
--5.79M
---19.14K
---33.04K
Basic earnings per share
-15.05%-0.22
-386.38%-0.48
19.34%-0.21
-0.37%-0.17
-1105.78%-0.19
25.44%-0.10
-48.90%-0.26
87.09%-0.17
99.44%-0.02
-442.42%-0.13
-763.73%-0.18
-1094.39%-1.31
-32278.18%-2.76
-39.65%0.04
-92.08%0.03
11958.56%0.13
546.35%0.01
--0.06
--0.34
--0.00
--0.00
Diluted earnings per share
-15.05%-0.22
-386.38%-0.48
19.34%-0.21
-0.37%-0.17
-1105.78%-0.19
25.44%-0.10
-48.90%-0.26
87.09%-0.17
99.44%-0.02
-442.42%-0.13
-763.73%-0.18
-1094.39%-1.31
-32278.18%-2.76
-39.65%0.04
-92.08%0.03
11958.56%0.13
546.35%0.01
--0.06
--0.34
--0.00
--0.00
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Zura Bio Ltd's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing ZURA stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Zura Bio Ltd's net income for the year?

Zura Bio Ltd posted -99.35M in net income for fiscal year 2025.

How much net income did Zura Bio Ltd post in the last quarter?

Zura Bio Ltd reported -24.22M in net income for the latest quarter。

What was Zura Bio Ltd's annual operating profit?

Zura Bio Ltd's operating income was -80.25M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.